1. Cancer associated mast cells exhibit a tumor promoting phenotype but can be effectively targeted to reinvigorate antitumor immunity in a human based ex-vivo model. (March 2019) Authors: Ferber, D.; Suarez-Carmona, M.; Lenoir, B.; Keß, S.; Schott, S.; Zörnig, I.; Jäger, D.; Halama, N. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human lung cancer explants model: Set up of a predictive model for treatment. (March 2019) Authors: Lenoir, B.M.A.; Ferber, D.S.; Eichhorn, F.; Eichhorn, M.; Zörnig, I.; Jäger, D.; Halama, N. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibition of the CD95 ligand protects liver from ischemia/reperfusion injury in mice. (April 2016) Authors: Al-Saeedi, M.; Steinebrunner, N.; Kudsi, H.; Halama, N.; Mogler, C.; Schemmer, P. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lipid-storing, tumor-associated macrophages orchestrate a tumor-excluded immune landscape in omentum metastases of epithelial ovarian cancer. (March 2019) Authors: Suarez-Carmona, M.; Valous, N.A.; Lenoir, B.M.A.; Hampel, M.; Kather, J.N.; Ferber, D.; Grauling-Halama, S.; Schott, S.; Kess, S.; Zörnig, I.; Jäger, D.; Halama, N. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Omental fat in ovarian cancer induces lymphangiogenesis – The role of an adipose-rich microenvironment in tumor progression and metastatic dissemination. (March 2019) Authors: Starrach, V.F.; Lenoir, B.; Ferber, D.; Suarez-Carmona, M.; Schott, S.; Zörnig, I.; Jäger, D.; Halama, N. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Omental fat in ovarian cancer induces lymphangiogenesis. (March 2018) Authors: Ferber, D.; Lenoir, B.; Suarez-Carmona, M.; Schott, S.; Zörnig, I.; Jäger, D.; Halama, N. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Omental fat in ovarian cancer induces metabolic and immune alterations. (March 2018) Authors: Suarez-Carmona, M.; Valous, N.A.; Hampel, M.; Lenoir, B.M.; Schott, S.; Eismann, S.; Zörnig, I.; Jäger, D.; Halama, N. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1. (February 2018) Authors: Haag, G.M.; Zoernig, I.; Hassel, J.C.; Halama, N.; Dick, J.; Lang, N.; Podola, L.; Funk, J.; Ziegelmeier, C.; Juenger, S.; Bucur, M.; Umansky, L.; Falk, C.S.; Freitag, A.; Karapanagiotou-Schenkel, I.; Beckhove, P.; Enk, A.; Jaeger, D. Journal: European journal of cancer Issue: Volume 90(2018) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Preclinical development of a therapeutic antibody for the treatment of epithelial ovarian carcinoma. (March 2018) Authors: Suarez-Carmona, M.; Ferber, D.S.; Momburg, F.; Meyer, M.; Hampel, M.; Lenoir, B.M.; Schott, S.; Zörnig, I.; Jäger, D.; Halama, N. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION. (23rd June 2022) Authors: Müller-Tidow, C.; Janssen, M.; Schäkel, U.; Gall, J.; Leo, A.; Stelmach, P.; Krisam, J.; Baumann, L.; Stermann, J.; Merle, U.; Zeier, M.; Weigand, M. A.; Bullinger, L.; Schrezenmeier, J.-F.; Bornhäuser, M.; Alakel, N.; Witzke, O.; Wolf, T.; Vehreschild, M. J.; Schmiedel, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗